My Crossword Maker Logo
Powered by BrightSprout
Save Status:
or to save your progress. The page will not refresh.
Controls:
SPACEBAR SWITCHES TYPING DIRECTION
Answer Key:
Edit a Copy:
Make Your Own:
Crossword Word Search Worksheet
Rate This Puzzle:
Log in or sign up to rate this puzzle.

Pharmacology CX #1

Across
Is the name of the Drug listed in the United States Pharmacopeia and the National Formulary. Generally the same as the Generic name. NOT protected by a patent.
Is the name of the Drug selected by the manufacturer who develops the medication and is approved by the United States Adopted Names (USAN) Council. NOT protected by a patent.
Is the fourth of four Phases of Pharmacokinetics. It is out the Drug leaves the body. The chemical make-up of the drug determines which organ of excretion. The KIDNEYS are the main organs that excrete Drugs. If the kidneys are effected by disease or damage, too much of the Drug can remain in the system, which can lead to TOXICITY of that drug.
Is the extent of drug absorption. The portion of the drug that enters the circulation when introduced so is able to have an active effect.
Down
Is the name that describes the Drugs atomic and molecular structure. Exact description of the composite of the Drug.
Is the second of four Phases of Pharmacokinetics. The transport of a drug in the body, by the bloodstream, to its site of action. The process by which the drug reaches its site.
Is the first of four Phases of Pharmacokinetics. Starts from the side of administration of the drug into the blood. The route, drug characteristics, blood flow to area, Body surface area, and gastrointestinal motility can have effect on this and on Bioavailability.
Is the third of four Phases of Pharmacokinetics. Also called biotransformation, is the breaking down and removal of biologically active components or chemicals. The organ MOST responsible for this is the LIVER. Diseases, aging, other drugs can make this process go slower and create an increase of drug in the system, which can lead to TOXICITY of that drug.
Is the protein that binds to and carries drugs throughout the body. Low______ creates low protein binding abilities therefore increases risk of circulating unbound drug, which leads to TOXICITY of that drug. (A couple of conditions with low_______ levels are patients with burns and patients malnourished.)
Is the name of the Drug select by the drug company selling the product. IS PROTECTED by a patent. You will see the patent symbol after the trade name that signifies it has be registered and restricted to the drug manufacture (the patent expires after seven years)